{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T12:27:20Z","timestamp":1793190440524,"version":"4.5.0"},"reference-count":35,"publisher":"American Medical Association (AMA)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Psychiatry"],"published-print":{"date-parts":[[2018,4,1]]},"DOI":"10.1001\/jamapsychiatry.2017.4711","type":"journal-article","created":{"date-parts":[[2018,2,28]],"date-time":"2018-02-28T12:30:58Z","timestamp":1519821058000},"page":"347","source":"Crossref","is-referenced-by-count":140,"title":["Real-world Effectiveness of Pharmacologic Treatments for the Prevention of Rehospitalization in a Finnish Nationwide Cohort of Patients With Bipolar Disorder"],"prefix":"10.1001","volume":"75","author":[{"given":"Markku","family":"L\u00e4hteenvuo","sequence":"first","affiliation":[{"name":"Department of Forensic Psychiatry, University of Eastern Finland, Niuvanniemi Hospital, Kuopio, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antti","family":"Tanskanen","sequence":"additional","affiliation":[{"name":"Department of Forensic Psychiatry, University of Eastern Finland, Niuvanniemi Hospital, Kuopio, Finland"},{"name":"Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden"},{"name":"Impact Assessment Unit, National Institute for Health and Welfare, Helsinki, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heidi","family":"Taipale","sequence":"additional","affiliation":[{"name":"Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden"},{"name":"Kuopio Research Centre of Geriatric Care, University of Eastern Finland, Kuopio, Finland"},{"name":"School of Pharmacy, University of Eastern Finland, Kuopio, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabian","family":"Hoti","sequence":"additional","affiliation":[{"name":"EPID Research Oy, Espoo, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pia","family":"Vattulainen","sequence":"additional","affiliation":[{"name":"EPID Research Oy, Espoo, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduard","family":"Vieta","sequence":"additional","affiliation":[{"name":"Hospital Clinic, Institute of Neuroscience, University of Barcelona, Institut d\u2019Investigacions Biom\u00e8diques August Pi i Sunyer, Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Salud Mental, Barcelona, Catalonia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jari","family":"Tiihonen","sequence":"additional","affiliation":[{"name":"Department of Forensic Psychiatry, University of Eastern Finland, Niuvanniemi Hospital, Kuopio, Finland"},{"name":"Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"5","key":"yoi170114r1","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1192\/apt.bp.107.004903","article-title":"The course of bipolar disorder.","volume":"16","author":"Saunders","year":"2010","journal-title":"Adv Psychiatr Treat"},{"issue":"9995","key":"yoi170114r2","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/S0140-6736(15)60692-4","article-title":"Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.","volume":"386","author":"Global Burden of Disease Study 2013 Collaborators","year":"2015","journal-title":"Lancet"},{"issue":"2","key":"yoi170114r3","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1176\/appi.ajp.163.2.217","article-title":"Predictors of recurrence in bipolar disorder: primary outcomes from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD).","volume":"163","author":"Perlis","year":"2006","journal-title":"Am J Psychiatry"},{"issue":"3","key":"yoi170114r4","doi-asserted-by":"publisher","first-page":"324","DOI":"10.4088\/JCP.16m11201","article-title":"Efficacy and safety of aripiprazole once-monthly in the maintenance treatment of bipolar I disorder: a double-blind, placebo-controlled, 52-week randomized withdrawal study.","volume":"78","author":"Calabrese","year":"2017","journal-title":"J Clin Psychiatry"},{"issue":"11","key":"yoi170114r5","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/j.euroneuro.2012.03.004","article-title":"A randomized, double-blind, placebo-controlled trial to assess prevention of mood episodes with risperidone long-acting injectable in patients with bipolar I disorder.","volume":"22","author":"Vieta","year":"2012","journal-title":"Eur Neuropsychopharmacol"},{"issue":"5","key":"yoi170114r6","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/S2215-0366(14)70314-1","article-title":"Comparative efficacy and tolerability of pharmacological treatments in the maintenance treatment of bipolar disorder: a systematic review and network meta-analysis.","volume":"1","author":"Miura","year":"2014","journal-title":"Lancet Psychiatry"},{"key":"yoi170114r7","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s40345-014-0015-8","article-title":"Lithium for prevention of mood episodes in bipolar disorders: systematic review and meta-analysis.","volume":"2","author":"Severus","year":"2014","journal-title":"Int J Bipolar Disord"},{"issue":"5","key":"yoi170114r8","doi-asserted-by":"publisher","first-page":"403","DOI":"10.2165\/11631310-000000000-00000","article-title":"Long-acting injectable antipsychotics for the maintenance treatment of bipolar disorder.","volume":"26","author":"Gigante","year":"2012","journal-title":"CNS Drugs"},{"issue":"2","key":"yoi170114r10","first-page":"180","article-title":"The International College of Neuro-Psychopharmacology (CINP) treatment guidelines for bipolar disorder in adults (CINP-BD-2017), part 3: the clinical guidelines.","volume":"20","author":"Fountoulakis","year":"2017","journal-title":"Int J Neuropsychopharmacol"},{"issue":"9","key":"yoi170114r11","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1002\/gps.4443","article-title":"Geriatric characteristics in randomised controlled trials on antidepressant drugs for older adults: a systematic review.","volume":"31","author":"Benraad","year":"2016","journal-title":"Int J Geriatr Psychiatry"},{"issue":"9","key":"yoi170114r12","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.0908e27","article-title":"Observational, pragmatic, and clinical trials in bipolar disorder.","volume":"69","author":"Vieta","year":"2008","journal-title":"J Clin Psychiatry"},{"issue":"1","key":"yoi170114r13","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1002\/wps.v15.1","article-title":"Lithium vs valproate vs olanzapine vs quetiapine as maintenance monotherapy for bipolar disorder: a population-based UK cohort study using electronic health records.","volume":"15","author":"Hayes","year":"2016","journal-title":"World Psychiatry"},{"issue":"1","key":"yoi170114r14","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1192\/bjp.bp.110.084822","article-title":"Valproate v lithium in the treatment of bipolar disorder in clinical practice: observational nationwide register-based cohort study.","volume":"199","author":"Kessing","year":"2011","journal-title":"Br J Psychiatry"},{"issue":"3","key":"yoi170114r15","doi-asserted-by":"publisher","first-page":"254","DOI":"10.4088\/JCP.13m08601","article-title":"A prospective 4-year naturalistic follow-up of treatment and outcome of 300 bipolar I and II patients.","volume":"75","author":"Simhandl","year":"2014","journal-title":"J Clin Psychiatry"},{"issue":"3","key":"yoi170114r16","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1192\/bjp.bp.116.187989","article-title":"Pharmacological treatment and risk of psychiatric hospital admission in bipolar disorder.","volume":"210","author":"Joas","year":"2017","journal-title":"Br J Psychiatry"},{"issue":"8","key":"yoi170114r17","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1176\/appi.ajp.2017.16050542","article-title":"Suicidal behavior during lithium and valproate treatment: a within-individual 8-year prospective study of 50,000 patients with bipolar disorder.","volume":"174","author":"Song","year":"2017","journal-title":"Am J Psychiatry"},{"issue":"9","key":"yoi170114r18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0184070","article-title":"Drug exposure in register-based research\u2014an expert-opinion based evaluation of methods.","volume":"12","author":"Tanskanen","year":"2017","journal-title":"PLoS One"},{"key":"yoi170114r19","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s12911-015-0140-z","article-title":"From prescription drug purchases to drug use periods\u2014a second generation method (PRE2DUP).","volume":"15","author":"Tanskanen","year":"2015","journal-title":"BMC Med Inform Decis Mak"},{"key":"yoi170114r20","doi-asserted-by":"publisher","first-page":"363","DOI":"10.2147\/CLEP","article-title":"Agreement between PRE2DUP register data modeling method and comprehensive drug use interview among older persons.","volume":"8","author":"Taipale","year":"2016","journal-title":"Clin Epidemiol"},{"issue":"7","key":"yoi170114r21","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/S2215-0366(17)30134-7","article-title":"Pharmacological treatments and risk of readmission to hospital for unipolar depression in Finland: a nationwide cohort study.","volume":"4","author":"Tiihonen","year":"2017","journal-title":"Lancet Psychiatry"},{"issue":"7","key":"yoi170114r22","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1001\/jamapsychiatry.2017.1322","article-title":"Real-world effectiveness of antipsychotic treatments in a nationwide cohort of 29 823 patients with schizophrenia.","volume":"74","author":"Tiihonen","year":"2017","journal-title":"JAMA Psychiatry"},{"issue":"3","key":"yoi170114r23","doi-asserted-by":"publisher","first-page":"473","DOI":"10.4088\/JCP.v67n0320","article-title":"A double-blind, randomized, placebo-controlled, prophylaxis study of adjunctive gabapentin for bipolar disorder.","volume":"67","author":"Vieta","year":"2006","journal-title":"J Clin Psychiatry"},{"issue":"3","key":"yoi170114r24","doi-asserted-by":"publisher","first-page":"449","DOI":"10.3109\/15563659309000412","article-title":"Clinical features in 28 consecutive cases of laboratory confirmed massive poisoning with carbamazepine alone.","volume":"31","author":"Hojer","year":"1993","journal-title":"J Toxicol Clin Toxicol"},{"issue":"4","key":"yoi170114r25","doi-asserted-by":"publisher","first-page":"445","DOI":"10.3109\/15563659009038587","article-title":"Carbamazepine overdose: a prospective study of serum levels and toxicity.","volume":"28","author":"Spiller","year":"1990","journal-title":"J Toxicol Clin Toxicol"},{"issue":"8","key":"yoi170114r26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002058","article-title":"Adverse renal, endocrine, hepatic, and metabolic events during maintenance mood stabilizer treatment for bipolar disorder: a population-based cohort study.","volume":"13","author":"Hayes","year":"2016","journal-title":"PLoS Med"},{"issue":"1","key":"yoi170114r27","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.pediatrneurol.2015.02.018","article-title":"Effect of carbamazepine and valproate monotherapy on cardiovascular risks in epileptic children.","volume":"53","author":"Harit","year":"2015","journal-title":"Pediatr Neurol"},{"issue":"14","key":"yoi170114r28","doi-asserted-by":"publisher","first-page":"E519","DOI":"10.1503\/cmaj.160126","article-title":"Risk of pneumonia associated with incident benzodiazepine use among community-dwelling adults with Alzheimer disease.","volume":"189","author":"Taipale","year":"2017","journal-title":"CMAJ"},{"issue":"2","key":"yoi170114r29","doi-asserted-by":"crossref","DOI":"10.4088\/PCC.16r02037","article-title":"Prescribed benzodiazepines and suicide risk: a review of the literature.","volume":"19","author":"Dodds","year":"2017","journal-title":"Prim Care Companion CNS Disord"},{"issue":"11","key":"yoi170114r30","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1016\/j.mayocp.2016.07.024","article-title":"Benzodiazepine use in older adults: dangers, management, and alternative therapies.","volume":"91","author":"Markota","year":"2016","journal-title":"Mayo Clin Proc"},{"issue":"6","key":"yoi170114r31","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1177\/1403494812456637","article-title":"Quality of the Finnish hospital discharge register: a systematic review.","volume":"40","author":"Sund","year":"2012","journal-title":"Scand J Public Health"},{"issue":"4","key":"yoi170114r32","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.euroneuro.2017.01.010","article-title":"Do patients with bipolar disorder and subsyndromal symptoms benefit from functional remediation? a 12-month follow-up study.","volume":"27","author":"Sanchez-Moreno","year":"2017","journal-title":"Eur Neuropsychopharmacol"},{"key":"yoi170114r33","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.jad.2014.02.034","article-title":"Verbal memory as a mediator in the relationship between subthreshold depressive symptoms and functional outcome in bipolar disorder.","volume":"160","author":"Bonn\u00edn","year":"2014","journal-title":"J Affect Disord"},{"issue":"5","key":"yoi170114r34","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.euroneuro.2011.09.008","article-title":"Polarity index of pharmacological agents used for maintenance treatment of bipolar disorder.","volume":"22","author":"Popovic","year":"2012","journal-title":"Eur Neuropsychopharmacol"},{"issue":"10027","key":"yoi170114r35","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1016\/S0140-6736(15)00241-X","article-title":"Bipolar disorder.","volume":"387","author":"Grande","year":"2016","journal-title":"Lancet"},{"key":"yoi170114r9","volume-title":"Bipolar Disorder: The Management of Bipolar Disorder in Adults, Children and Adolescents, in Primary and Secondary Care. GC38","author":"National Institute for Health and Care Excellence","year":"2006"}],"container-title":["JAMA Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamapsychiatry\/articlepdf\/2673379\/jamapsychiatry_lhteenvuo_2018_oi_170114_1646761265.08956.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,9]],"date-time":"2022-03-09T11:17:55Z","timestamp":1646824675000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamapsychiatry\/fullarticle\/2673379"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,1]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,4,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamapsychiatry.2017.4711","relation":{},"ISSN":["2168-622X"],"issn-type":[{"value":"2168-622X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4,1]]}}}